510(k) Report

510(k) · Cleared

Cleared

iQ-solutions

K231929510(k) TraditionalCleared Dec 18, 2023171-day reviewClass II21 CFR 892.2050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Sydney Neuroimaging Analysis Centre Pty, Ltd. · QIH Automated Radiological Image Processing Software

Cleared on Dec 18, 2023 as substantially equivalent to K192130 (Icometrix NV, 2019) after a 171-day review. Its family tree reaches back 5 generations to 2006.

Decided
Dec 18, 2023
Review
171 days
Class
Class II
Product code
QIH
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K061855 (2006). No later device cites it as a predicate yet.

  1. Root · 5 generations backK061855 NeuroquantCortechs Labs, Inc. · 2006
  2. 4 generations backK161148 icobrainIcometrix · 2016
  3. 3 generations backK180326 icobrainIcometrix · 2018
  4. 2 generations backK181939 icobrainIcometrix NV · 2018
  5. 1 generation backK192130 IcobrainIcometrix NV · 2019
  6. This deviceK231929 iQ-solutionsSydney Neuroimaging Analysis Centre Pty, Ltd. · 2023
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K061855NeuroquantCortechs Labs, Inc.2006—
−4K161148icobrainIcometrix2016—
−3K180326icobrainIcometrix2018—
−2K181939icobrainIcometrix NV2018—
−1K192130IcobrainIcometrix NV2019—
0 (this device)K231929iQ-solutionsSydney Neuroimaging Analysis Centre Pty, Ltd.2023—
FIG. 1 — Lineage of K231929, 2006–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QIH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QIH device

  1. #1 K213998 cvi42 Auto Imaging Software Applicationscore 23.5 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K192130Icobrain
Summary page 5
…H, LLZ 5.3 Predicate Device Product Name: icobrain Device Trade Name: Icobrain 510(k) Number K192130 Clearance Date: December 13, 2019 Manufacturer: icometrix NV Common Name…
Icometrix NV2019—

Also cleared against K192130: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 17 years and passes through 4 companies; a new generation was cleared every 1.6 years on median.
  • None of the 5 ancestors has a recall.
  • 2 other devices also cite its predicate K192130.

How does its category compare?

All QIH devices

QIH Automated Radiological Image Processing Software: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · QIH

94in 2025

2019: 22020: 112021: 192022: 252023: 452024: 642025: 942026 (partial year): 78
2007high 94 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QIH

150in 2025

2020: 145 days median2021: 125 days median2022: 134 days median2023: 151 days median2024: 141 days median2025: 150 days median2026 (partial year): 130 days median
2007high 151 (2023) · low 125 (2021)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QIH

1so far in 2026, the most since 2007

2026 (partial year): 1
2007high 1 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · QIH

4in 2025

2024: 22025: 4
2007high 4 (2025) · low 0 (2007)2025

MAUDE reports naming product code QIH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20192—00
20201114500
20211912500
20222513400
20234515100
20246414102
20259415004
2026781301—

What is it indicated for?

1Q-solutions™ is a software medical device intended for automatic annotation, visualization, and quantification of segmentable brain structures from a set of brain MRI scans. It is intended to accelerate and improve the quantification of brain structures that would otherwise require a manual process of identifying, annotating, and measuring regions of interest in brain MRI scans. 1Q-solutions™ consists of both cross-sectional and longitudinal analysis…

Read the full statement (137 words)

1Q-solutions™ is a software medical device intended for automatic annotation, visualization, and quantification of segmentable brain structures from a set of brain MRI scans. It is intended to accelerate and improve the quantification of brain structures that would otherwise require a manual process of identifying, annotating, and measuring regions of interest in brain MRI scans.

1Q-solutions™ consists of both cross-sectional and longitudinal analysis pipelines.

» The cross-sectional pipeline is intended to conduct structure segmentation and volume analysis on brain MRI scans at a single time point.

The longitudinal pipeline is intended to conduct volume change analysis on a single patient’s MRI scans acquired on the same scanner, with consistent image acquisition protocol and with consistent contrast at two different time points.

The results of the cross-sectional pipeline cannot be compared with the results of the longitudinal pipeline.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K231929: iQ-solutions.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K231929

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026